Company Filing History:
Years Active: 1996
Title: Karl-Heinrich Fritzmeier: Innovator in Estradiol Derivatives
Introduction
Karl-Heinrich Fritzmeier is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of chemistry, particularly in the development of new derivatives of estradiol. His work has implications in various applications, showcasing the importance of innovation in the pharmaceutical industry.
Latest Patents
Fritzmeier holds a patent for "15,15-dialkyl-substituted derivatives of estradiol." This patent describes new 15,15-dialkyl-substituted derivatives of estradiol, characterized by a general formula where R¹ and R² can be hydrogen atoms or various alkanoyl groups. The patent highlights the versatility of these derivatives, which can include straight-chain and branched-chain alkanoyl groups, as well as alkanoyl groups containing cycloaliphatic structures or benzoyl groups. He has 1 patent to his name.
Career Highlights
Fritzmeier has been associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical sector. His work at Schering has allowed him to focus on innovative solutions in drug development and chemical synthesis. His contributions have been instrumental in advancing the understanding of estradiol derivatives.
Collaborations
Throughout his career, Fritzmeier has collaborated with esteemed colleagues, including James R. Bull and Christa Hegele-Hartung. These collaborations have fostered a productive environment for research and innovation, leading to significant advancements in their respective fields.
Conclusion
Karl-Heinrich Fritzmeier's work exemplifies the impact of innovation in the pharmaceutical industry. His patent on estradiol derivatives showcases his commitment to advancing scientific knowledge and improving health outcomes. His contributions continue to influence the field and inspire future research.